Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations;Carcinomas ductales infiltrantes de mama en mujeres mayores de 60 años. Asociación con mayor proliferación celular y menores concentraciones de pS2 y ácido hialurónico citosólico y de membrana

Revista española de medicina nuclear

Volumn 20, Issue 7, 2001, Pages 525-529

  Ruibal, A ^a   Arias, J ^b   Del Rio M C ^c   Resino, C ^a   Tejerina, A ^a,d  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Hospital Monte del Naranco   (Spain)

^c UNIVERSIDAD ALFONSO X EL SABIO   (Spain)

^d Centro de Patologia de la Mama   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; HYALURONIC ACID; MEMBRANE PROTEIN; PROGESTERONE RECEPTOR; PROTEIN; TFF1 PROTEIN, HUMAN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST TUMOR; CELL CYCLE S PHASE; CHEMISTRY; CYTOPLASM; FEMALE; HUMAN; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CATHEPSIN D; CYTOPLASM; DNA, NEOPLASM; FEMALE; HUMANS; HYALURONIC ACID; LYMPHATIC METASTASIS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; S PHASE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR SUPPRESSOR PROTEINS;

EID: 0035650935     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0212-6982(01)72007-1     Document Type: Article

References (26)

1. N. Edwards D. Jones Uptake of breast cancer screening in older women Age and Ageing 29 2000 131 135
2. E. Yildirim T. Dalgic U. Berberoglu Prognostic significance of young age in breast cancer J Surg Oncol 74 2000 267 272
3. A. Chan M. Pintilie K. Vallis C. Girourd P. Goss Breast cancer in women > or = 35 years: review of 1,002 cases from a single institution Ann Oncol 11 2000 1255 1262
4. G.H. Lyman S. Lyman L. Balducci N. Kuderer D. Reintgen C. Cox Age and the risk of breast cancer recurrence Cancer Control 3 1996 421 427
5. E.L. Trimble Cancer biology and aging Proc Asco 19 2000 92 98
6. F. Ashkanani O. Eremin S.D. Heys The management of cancer of the breast in the elderly Eur J Surg Oncol 24 1998 396 402
7. A. Lluch E. Martínez F. Prosper T. García J.M. Sastre P. Azaga Age as a prognostic factor in patients with breast cancer: relationship with pathological and biological features Proc. ASCO 19 2000 1469 (Abstract).
8. T.H. Gruenberger M. Gnant M. Mittboeck I. Axner S. Kandioler S. Taucher Age as an independent risk factor for relapse after primary breast cancer treatment Proc. ASCO 17 1997 1359 (Abstract).
9. S.G. Diab R.M. Elledge G.M. Clark Tumor characteristics and clinical outcome of elderly women with breast cancer J Natl Cancer Inst 92 2000 550 556
10. Ershler W.B. Do old people get old tumors. ASCO 2000. Eduacational Book. p. 87-90
11. A. Ruibal J.I. Arias M.C. del Río J.M. San Román C. Resino A. Tejerina Influencia de la proliferación celular sobre ciertas características clínico-biológicas de los carcinomas mamarios Cir Esp 68 2000 427 431
12. P. Rudoplh P. Alm H.J. Heidebrecht H. Bolte V. Ratjen B. Baldetorp Immunologic proliferation marker Ki-S2 as prognostic indicator for lymh node negative breast cancer J Natl Cancer Inst 91 1999 271 278
13. A.E. Pinto S. Andre J. Soares Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients J Clin Pathol 52 1999 604 611
14. B.E. Guillesby T.R. Zacharewski pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers Breast Cancer Res Treat 56 1999 253 265
15. Y. Lugmani L. Temmin A. Memon A. Parkar M. Ali M. Motaway Immunoradiometric measurement of pS2 in breast cancer-correlation with steroid receptors and plasminogen activators Acta Oncol 38 1999 805 814
16. S.J. Reshkin T. Tedone M. Correale A. Mangia U. Casavola A. Paradiso Association of pS2 (TFF1) release with breast tumor proliferative rate: in vitro and in vivo studies Cell Prolif 32 1999 107 118
17. P. Speiser J. Stolzlechner K. Haider H. Heinzl R. Jakesz M. Pecherstorfer pS2 protein fails to be an independent prognostic factor in an average breast cancer Anticancer Res 14 1994 2125 2130
18. J.A. Foekens H. Portengen M.P. Look W.L.J. Van Putten B. Thirion M. Bontenbal Relationship of pS2 with response to tamoxifen therapy in patients with recurrent breast cancer Br J Cancer 70 1994 1217 1223
19. A. Ruibal M.I. Núñez A. Tejerina Hyaluronic acid concentrations in cell membranes are inversely proportional to histological grade and ploidy in infiltrating ductal carcinoma of the breast Rev Esp Med Nucl 17 1998 310 311
20. A. Ruibal J. Arias M.C. del Río J.M. San Román C. Pardo J. Schneider Estudio del ácido hialurónico en la membrana celular de procesos mamarios benignos y malignos. Corelaciones clínico-biológicas Cir Esp 67 2000 551 555
21. A. Ruibal J. Schneider M.C. del Río J.I. Arias M.J. Núñez A. Tejerina La expresíón de la molécula de adhesión CD44v6 en carcinomas ductales infiltrantes de mama se asocia con la hormonodependencia Rev Esp Med Nuclear 19 2000 350 355
22. C. Tempfer A. Losch H. Heimzl G. Hausler E. Hanzal H. Kolb Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer Eur J Cancer 32 1996 2023 2025
23. J.A. Foekens P. Dall J.G. Klinjn P. Skroch-Ángel C.J. Claassen M.P. Look Prognostic value of CD44 variant expression in primary breast cancer Int J Cancer 84 1999 209 215
24. A. Ruibal J.I. Arias A. Suárez M.C. del Río G. Lapeña J. Schneider Diferencias clínico-biológicas de los carcinomas ductales infiltrantes de mama CD44v5 positivos clasificados en función de la concentración de ácido hialurónico de la membrana celular Cir Esp 69 2001 451 454
25. Ruibal A., Arias J.I., del Río M.C., San Román J.M., Sánchez Martin J.A., Sánchez Hermosa C, et al. Influencia de la concentración de ácido hialurónico, citosólico y de membrana, sobre ciertas propiedades clínico-biológicas de los carcinomas ductales infiltrantes de mama CD44v6 positivos. Cir Esp (En prensa)
26. A. Ruibal J.I. Arias M.C. del Río G. Lapeña J. Schneider A. Tejerina La concentración de ácido hialurónico citosólico define ciertas propiedades clínico-biológicas del carcinoma ductal infiltrante de mama CD44v5 positivo Med Clin 115 2000 205 207